**Core Concept**
Valproate is a known teratogenic antiepileptic medication that increases the risk of congenital malformations, particularly neural tube defects, in the fetus. The teratogenic effects of valproate are dose-dependent and associated with its mechanism of action as a GABA receptor antagonist.

**Why the Correct Answer is Right**
Valproate's teratogenic effects are thought to be related to its inhibition of the enzyme dihydrofolate reductase (DHFR), which is essential for the synthesis of tetrahydrofolate (THF), a crucial cofactor in nucleic acid synthesis. This inhibition disrupts the normal development of the neural tube and other structures in the fetus. Additionally, valproate's ability to induce hepatic enzyme CYP2C9 leads to increased levels of its own active metabolites, further contributing to its teratogenic effects. Given the risks associated with valproate use during pregnancy, alternative antiepileptic medications should be considered.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, so we'll skip to the next incorrect option.
**Option B:** Discontinuing valproate abruptly can lead to withdrawal seizures, making this option a poor choice.
**Option C:** Continuing valproate without discussing the risks and potential alternatives with the patient is not a responsible course of action.
**Option D:** This option is not provided, so we'll skip to the next incorrect option.

**Clinical Pearl / High-Yield Fact**
When counseling patients on the use of antiepileptic medications during pregnancy, it's essential to discuss the risks and benefits of each option and consider switching to alternative medications, such as lamotrigine or levetiracetam, which have a lower teratogenic potential.

**Correct Answer:** C.